Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 105
- 试验地点
- 2
- 主要终点
- Change of pulse wave velocity (PWV) measurement from baseline
研究概览
简要总结
Acute kidney injury (AKI) is a frequent disease in conventional hospital departments and in intensive care units. It's associated with a high risk to develop chronic kidney disease (CKD), even after a single small AKI episode. It's also associated with an important morbi-mortality, particularly cardiovascular (CV). Some studies have already showed a link between AKI and CV risk but pathologic mechanisms implicated are still unknown. In AKI and CKD, numerous substances, called uremic toxins (UT) are accumulating in blood. In CKD, those toxins, and particularly Indoxyl sulfate (IS), are known to have cardiac and vascular deleterious consequences. However, in AKI, whether acute accumulation of UT may trigger CV complications is unknown.
The purpose of this study is that during AKI, a high UT concentration, in particular IS, would be associated with early vascular and cardiac dysfunctions that can be characterized by the persistence of an accelerated pulse wave velocity (PWV). The main objective is to evaluate the correlation between UT concentrations (especially IS) and arterial stiffness (PWV measurement) at three months of an AKI episode in conventional hospital departments and in the intensive care unit of nephrology.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age over 18 years old.
- •Patients hospitalized in conventional hospital departments and in intensive care units of nephrology.
- •Patients with moderate to severe AKI (KDIGO 2 or 3) without dialysis.
- •AKI from functional or organic aetiology
排除标准
- •Patients with severe CKD (GFR<45ml/min/1.73 m2) or with kidney transplants.
- •Patients with AKI from septic or obstructive aetiology.
- •Patients with AKI from toxic aetiology whose toxic would be also responsable of cardia toxicity.
- •Patients with sepsis or blood inflammation.
- •Patients with severe chronic cardia dysfunction.
- •Patients with arrhythmia or complete heart block.
- •Patients with peripheral artery occlusive disease.
- •Pregnancy.
- •Patients on palliative care.
结局指标
主要结局
Change of pulse wave velocity (PWV) measurement from baseline
时间窗: at 3 months
次要结局
- Correlation between Para-cresyl Sulfate (PCS) concentration and PWV(3 months)
- Correlation between Fibroblast Growth Factor 23 (FGF23) concentration and PWV(3 months)
- Correlation between Fibroblast Growth Factor 23 (FGF23) concentration and cardiac diastolic function(3 months)
- Correlation between IS concentration and arterial pressure measurement(3 months)
- Correlation between Fibroblast Growth Factor 23 (FGF23) concentration and arterial pressure measurement(3 months)
- Correlation between IS concentration and cardiac diastolic function(3 months)
- Correlation between Para-cresyl Sulfate (PCS) concentration and arterial pressure measurement(3 months)
- Correlation between Para-cresyl Sulfate (PCS) concentration and cardiac diastolic function(3 months)
